Aptose Biosciences Inc. (APTOF)
OTCMKTS
· Delayed Price · Currency is USD
2.660
+0.650 (32.34%)
Apr 3, 2025, 4:00 PM EST
Aptose Biosciences Statistics
Total Valuation
APTOF has a market cap or net worth of 4.99 million. The enterprise value is 7.77 million.
| Market Cap | 4.99M |
| Enterprise Value | 7.77M |
Important Dates
The next estimated earnings date is Friday, May 9, 2025.
| Earnings Date | May 9, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +210.43% |
| Shares Change (QoQ) | +91.58% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.69M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.31 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.22 |
Financial Position
The company has a current ratio of 2.14
| Current Ratio | 2.14 |
| Quick Ratio | 1.38 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.30 |
| Interest Coverage | -126.85 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -141.98% |
| Return on Invested Capital (ROIC) | -779.60% |
| Return on Capital Employed (ROCE) | -463.25% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -706,389 |
| Employee Count | 36 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -94.20% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -94.20% |
| 50-Day Moving Average | 4.27 |
| 200-Day Moving Average | 10.33 |
| Relative Strength Index (RSI) | 41.70 |
| Average Volume (20 Days) | 57,670 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -26.26M |
| Pretax Income | -25.43M |
| Net Income | -25.43M |
| EBITDA | -26.23M |
| EBIT | -26.26M |
| Earnings Per Share (EPS) | -36.38 |
Balance Sheet
The company has 6.15 million in cash and 10.64 million in debt, giving a net cash position of -4.49 million.
| Cash & Cash Equivalents | 6.15M |
| Total Debt | 10.64M |
| Net Cash | -4.49M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -4.54M |
| Book Value Per Share | -2.26 |
| Working Capital | 5.07M |
Cash Flow
In the last 12 months, operating cash flow was -35.98 million and capital expenditures -5,000, giving a free cash flow of -35.98 million.
| Operating Cash Flow | -35.98M |
| Capital Expenditures | -5,000 |
| Free Cash Flow | -35.98M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
APTOF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -210.43% |
| Shareholder Yield | -210.43% |
| Earnings Yield | -509.28% |
| FCF Yield | -720.61% |
Stock Splits
The last stock split was on February 26, 2025. It was a reverse split with a ratio of 0.0333333.
| Last Split Date | Feb 26, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.0333333 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |